Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dolby Laboratories (DLB) Operating Expenses (2016 - 2025)

Dolby Laboratories' Operating Expenses history spans 17 years, with the latest figure at $241.3 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 2.11% year-over-year to $241.3 million; the TTM value through Dec 2025 reached $929.0 million, up 3.92%, while the annual FY2025 figure was $924.0 million, 5.62% up from the prior year.
  • Operating Expenses reached $241.3 million in Q4 2025 per DLB's latest filing, up from $237.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $258.5 million in Q3 2023 to a low of $199.1 million in Q2 2021.
  • Average Operating Expenses over 5 years is $224.7 million, with a median of $224.2 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: rose 25.25% in 2022, then decreased 13.17% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $228.3 million in 2021, then fell by 9.62% to $206.4 million in 2022, then grew by 5.29% to $217.3 million in 2023, then rose by 8.77% to $236.3 million in 2024, then grew by 2.11% to $241.3 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Operating Expenses are $241.3 million (Q4 2025), $237.8 million (Q3 2025), and $223.9 million (Q2 2025).